ArticleMedical oncology (Northwood, London, England)2018

Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.

Tomonori Nakazato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.